Skip to main content

enVVeno Medical Corp

NVNO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001661053

In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding enVVeno Medical Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of NVNO: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders1416+2
Shares897.6K841.9K−55.8K (−6.2%)
Value$6.16M$8.74M+$2.57M (+41.7%)

New holders (7)

Institutions that held enVVeno Medical Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to NVNO in Q3 2021
InstitutionSharesValue% of portfolio
ACT Capital Management, LLC262,500$2.73M1.41%
Morgan Stanley171,544$1.78M0.00%
L & S Advisors Inc30,000$311.0K0.03%
Susquehanna Fundamental Investments, LLC15,842$164.0K0.00%
Marshall Wace, LLP12,207$127.0K0.00%
Millennium Management LLC10,879$113.0K0.00%
Bank of America Corp9,356$97.0K0.00%

Sold out (5)

Institutions that held enVVeno Medical Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of NVNO in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
AIGH Capital Management LLC346,885$2.38M
Worth Venture Partners, LLC82,886$569.0K
Kepos Capital LP71,428$491.0K
Geode Capital Management, LLC63,753$437.0K
Tower Research Capital LLC (TRC)184$1.00K